Totaligent, Inc. (TGNT) stock
TGNTOTCShort-Term Business Credit InstitutionsFiscal year ends December 31
$0.01+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.31MP/E –Yield –
Totaligent r&d expenses
Research and development expenses are spending on new products and technology.
Totaligent's R&D Expenses for the twelve months ending Jun 30, 2015 was $815.85K, up 46.4% year over year. For fiscal 2015 it was $815.85K, up 46.4% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2015 | Jun 30, 2015 | $815.85K | +46.4% |
| FY2014 | Jun 30, 2014 | $557.39K | +18.0% |
| FY2013 | Jun 30, 2013 | $472.23K | +2415.2% |
| FY2011 | Jan 31, 2011 | $18.78K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2017CQ1 2017 | Sep 30, 2017 | $94.99K | -52.7% |
| Q2 FY2017CQ4 2016 | Jun 30, 2017 | $104.64K | -19.8% |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | $292.43K | +12.2% |
| Q3 FY2015CQ1 2015 | Mar 31, 2015 | $192.03K | +146.6% |
| Q2 FY2015CQ4 2014 | Dec 31, 2014 | $200.85K | +83.6% |
| Q1 FY2015CQ3 2014 | Sep 30, 2014 | $130.54K | +19.3% |
| Q4 FY2014CQ2 2014 | Jun 30, 2014 | $260.74K | +128.7% |
| Q3 FY2014CQ1 2014 | Mar 31, 2014 | $77.86K | -36.2% |
| Q2 FY2014CQ4 2013 | Dec 31, 2013 | $109.40K | +482.7% |
| Q1 FY2014CQ3 2013 | Sep 30, 2013 | $109.40K | – |
| Q4 FY2013CQ2 2013 | Jun 30, 2013 | $114.02K | – |
| Q3 FY2013CQ1 2013 | Mar 31, 2013 | $122.09K | – |
| Q4 FY2011CQ4 2010 | Jan 31, 2011 | $18.78K | – |
| Q3 FY2011CQ3 2010 | Oct 31, 2010 | $0 | – |
| Q2 FY2011CQ2 2010 | Jul 31, 2010 | $0 | – |
See a number that looks wrong?